Transcutaneous Vagus Nerve Stimulation for Motor Recovery After Stroke



Status:Suspended
Conditions:Neurology, Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:1/12/2019
Start Date:May 17, 2018
End Date:January 2020

Use our guide to learn which trials are right for you!

Safety and Effectiveness of Transcutaneous Vagus Nerve Stimulation Therapy to Improve Motor Recovery After Stroke

This study will evaluate the safety and effectiveness of Respiratory-gated Auricular Vagal
Afferent Nerve Stimulation (RAVANS) for improving motor recovery after stroke. Subacute
stroke patients will receive RAVANS or sham stimulation concurrent with arm motor training
during 10 intervention sessions occurring daily for 30 minutes over 2 weeks. The safety and
improvements in arm motor function after the intervention will be compared in patients
receiving RAVANS to those receiving sham stimulation.

This study will evaluate the safety, feasibility and effectiveness of Respiratory-gated
Auricular Vagal Afferent Nerve Stimulation (RAVANS) for improving motor recovery after
stroke. Subacute stroke patients will be randomized to RAVANS or sham stimulation groups.
Patients will receive RAVANS or sham stimulation concurrent with arm motor training during 10
sessions occurring daily for 30 minutes over 2 weeks. Safety will be compared in patients
receiving RAVANS to those receiving sham stimulation. Feasibility will be evaluated by
recruitment into the study and retention of enrolled patients. Changes in arm motor function
will be compared between RAVANS and sham stimulation groups from baseline to immediately
after the intervention period and to function at 3-months after stroke.

Inclusion Criteria:

- Supratentorial ischemic or hemorrhagic stroke incurred 4-30 days prior;

- Contralesional UL motor impairment defined by NIHSS item 5 score 1 or 2 (scale 0-4);

- Age ≥ 18;

- Able to provide written informed consent.

Exclusion Criteria:

- Implanted electronic device (e.g., pacemaker, neurostimulator);

- Pregnancy;

- Major psychiatric or medical condition that could interfere with study participation;

- Medical condition affecting left ear that could interfere with delivering RAVANS
(e.g., wound, infection, malignancy, hypoesthesia);

- Significant pre-existing disability of stroke-affected UL in activities of daily
living due to prior stroke or other medical cause defined by Stroke Impact Scale item
7 (SIS-hand) mean score < 4 (scale: 0-5);

- History of seizure during year before stroke or > 1 post-stroke seizure;

- Significant cognitive or language impairment that would interfere with informed
consent or study participation;

- Severe dysphagia;

- Bradycardia defined as resting heart rate < 50 bpm;

- Nonsustained ventricular tachycardia;

- Cardiac conduction disorder (i.e., bundle branch block, heart block, long Q-T
syndrome);

- History of asystole;

- History of recurrent vaso-vagal syncope;

- Hypotension defined as blood pressure < 90/60 mmHg.
We found this trial at
1
site
300 1st Avenue
Boston, Massachusetts 02129
617-952-5000
Spaulding Rehabilitation Hospital At Spaulding Rehabiliation Hospital Boston, our unique approach to therapy includes use...
?
mi
from
Boston, MA
Click here to add this to my saved trials